Minerva SA   Report issue

For profit Phase 1 Phase 4
Founded: Barretos Brazil (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2008
NCT00793364
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Minerva Biotechnologies Corporation

Active Ingredients

Drugs in Phase 4 Trials (1)

phytosterol (1 trial)

Drugs in Phase 1 Trials (1)

humnc2-car44 car t cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Hypercholesterolemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2